Everest Medicines Limited 雲頂新耀有限公司

Pay for financial year ended 2023-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

CNY '000

Directors

1 Chui, Hoi Yam 徐海音 INED 352 352
2 Fu, Wei (1982) 傅唯 Ch
3 Gong, Yubo 龔聿波 NED
4 Jiang, Shidong (1968) 蔣世東 INED 352 49 401
5 Kang, Lan 康嵐 NED
6 Li, Yifan (1967) 李軼梵 INED 352 49 401
7 Luo, Yongqing (1969) 羅永慶 CEO 7,328 3,600 68 19,726 30,722
8 Tan, Bo (1973) 譚擘 INED -147 -147
9 Woo, Ian Ying 何穎 Pres, FD 5,695 5,514 140 7,115 18,464
10 Zhang, Xiaofan (SFC:ANY097) 張曉帆 ED, COO 1,280 -9,124 -7,844
Total 1,056 14,303 9,114 208 17,668 42,349

Main board pay history

Click on the year-end to see the pay details.

CNY'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2024-12-31 1,077 12,631 32,274 220 26,332 72,534 Report
2023-12-31 1,056 14,303 9,114 208 17,668 42,349 Report
2022-12-31 1,008 18,024 14,127 139 35,430 68,728 Report
2021-12-31 966 18,058 21,102 0 66,261 106,387 Report
2020-12-31 276 12,438 26,680 27 44,441 83,862 Report
Total 4,383 75,454 103,297 594 190,132 373,860

Want to see more years here? volunteer to be a Webb-site editor and add the data from annual reports!


Sign up for our free newsletter

Recommend Webb-site to a friend

Copyright & disclaimer, Privacy policy

Back to top